Insulin Sensitivity, Lipids, and Blood Pressure in Young American Blacks

The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 6...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 15; no. 11; pp. 1798 - 1804
Main Authors Falkner, Bonita, Kushner, Harvey, Tulenko, Thomas, Sumner, Anne E., Marsh, Julian B.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Heart Association, Inc 01.11.1995
Hagerstown, MD Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 60 normotensive (Nt) subjects and 36 subjects with borderline hypertension (BHt), defined as blood pressure > 135/85 mm Hg. None of the subjects were diabetic or receiving antihypertension medication. All participants had blood pressure and anthropometric measurements, a fasting lipid profile, an oral glucose tolerance test, and a euglycemic hyperinsulinemic clamp. Insulin-stimulated glucose utilization (M), determined by insulin clamp, was significantly lower in the BHt subjects compared with the Nt subjects (men, Nt 6.91 plus/minus 0.62 versus BHt 5.54 plus/minus 0.65; women, Nt 5.97 plus/minus 0.47 versus BHt 3.79 plus/minus 0.38 mg times kg sup -1 times min sup -1, P = .006). When M was corrected for adiposity and expressed in milligrams per kilogram of fat free mass (M'), the difference between Nt and BHt remained significant (P = .006). There was a significant correlation of M' with systolic blood pressure (r = -.393, P < .0001), HDL-C (r = .382, P < .0001), triglyceride level (r = -.308, P < .001), apolipoprotein A-I (r = .190, P = .033), and apolipoprotein B (r = -.277, P = .004). When all lipid variables were entered in a stepwise multiple linear regression analysis, HDL-C emerged as the most significant lipid component in the model for insulin resistance. These data suggest that in American blacks with mild hypertension, the risk for cardiovascular disease may be augmented in the presence of insulin resistance. (Arterioscler Thromb Vasc Biol. 1995;15:1798-1804.)
AbstractList The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 60 normotensive (Nt) subjects and 36 subjects with borderline hypertension (BHt), defined as blood pressure > 135/85 mm Hg. None of the subjects were diabetic or receiving antihypertension medication. All participants had blood pressure and anthropometric measurements, a fasting lipid profile, an oral glucose tolerance test, and a euglycemic hyper-insulinemic clamp. Insulin-stimulated glucose utilization (M), determined by insulin clamp, was significantly lower in the BHt subjects compared with the Nt subjects (men, Nt 6.91 +/- 0.62 versus BHt 5.54 +/- 0.65; women, Nt 5.97 +/- 0.47 versus BHt 3.79 +/- 0.38 mg.kg-1.min-1, P = .006). When M was corrected for adiposity and expressed in milligrams per kilogram of fat free mass (M'), the difference between Nt and BHt remained significant (P = .006). There was a significant correlation of M' with systolic blood pressure (r = .393, P < .0001), HDL-C (r = .382, P < .0001), triglyceride level (r = 308, P < .001), apolipoprotein A-I (r = .190, P = .033), and apolipoprotein B stepwise multiple linear regression analysis, HDL-C emerged as the most significant lipid component in the model for insulin resistance. These data suggest that in American blacks with mild hypertension, the risk for cardiovascular disease may be augmented in the presence of insulin resistance.The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 60 normotensive (Nt) subjects and 36 subjects with borderline hypertension (BHt), defined as blood pressure > 135/85 mm Hg. None of the subjects were diabetic or receiving antihypertension medication. All participants had blood pressure and anthropometric measurements, a fasting lipid profile, an oral glucose tolerance test, and a euglycemic hyper-insulinemic clamp. Insulin-stimulated glucose utilization (M), determined by insulin clamp, was significantly lower in the BHt subjects compared with the Nt subjects (men, Nt 6.91 +/- 0.62 versus BHt 5.54 +/- 0.65; women, Nt 5.97 +/- 0.47 versus BHt 3.79 +/- 0.38 mg.kg-1.min-1, P = .006). When M was corrected for adiposity and expressed in milligrams per kilogram of fat free mass (M'), the difference between Nt and BHt remained significant (P = .006). There was a significant correlation of M' with systolic blood pressure (r = .393, P < .0001), HDL-C (r = .382, P < .0001), triglyceride level (r = 308, P < .001), apolipoprotein A-I (r = .190, P = .033), and apolipoprotein B stepwise multiple linear regression analysis, HDL-C emerged as the most significant lipid component in the model for insulin resistance. These data suggest that in American blacks with mild hypertension, the risk for cardiovascular disease may be augmented in the presence of insulin resistance.
The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 60 normotensive (Nt) subjects and 36 subjects with borderline hypertension (BHt), defined as blood pressure > 135/85 mm Hg. None of the subjects were diabetic or receiving antihypertension medication. All participants had blood pressure and anthropometric measurements, a fasting lipid profile, an oral glucose tolerance test, and a euglycemic hyperinsulinemic clamp. Insulin-stimulated glucose utilization (M), determined by insulin clamp, was significantly lower in the BHt subjects compared with the Nt subjects (men, Nt 6.91 plus/minus 0.62 versus BHt 5.54 plus/minus 0.65; women, Nt 5.97 plus/minus 0.47 versus BHt 3.79 plus/minus 0.38 mg times kg sup -1 times min sup -1, P = .006). When M was corrected for adiposity and expressed in milligrams per kilogram of fat free mass (M'), the difference between Nt and BHt remained significant (P = .006). There was a significant correlation of M' with systolic blood pressure (r = -.393, P < .0001), HDL-C (r = .382, P < .0001), triglyceride level (r = -.308, P < .001), apolipoprotein A-I (r = .190, P = .033), and apolipoprotein B (r = -.277, P = .004). When all lipid variables were entered in a stepwise multiple linear regression analysis, HDL-C emerged as the most significant lipid component in the model for insulin resistance. These data suggest that in American blacks with mild hypertension, the risk for cardiovascular disease may be augmented in the presence of insulin resistance. (Arterioscler Thromb Vasc Biol. 1995;15:1798-1804.)
The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 60 normotensive (Nt) subjects and 36 subjects with borderline hypertension (BHt), defined as blood pressure > 135/85 mm Hg. None of the subjects were diabetic or receiving antihypertension medication. All participants had blood pressure and anthropometric measurements, a fasting lipid profile, an oral glucose tolerance test, and a euglycemic hyper-insulinemic clamp. Insulin-stimulated glucose utilization (M), determined by insulin clamp, was significantly lower in the BHt subjects compared with the Nt subjects (men, Nt 6.91 +/- 0.62 versus BHt 5.54 +/- 0.65; women, Nt 5.97 +/- 0.47 versus BHt 3.79 +/- 0.38 mg.kg-1.min-1, P = .006). When M was corrected for adiposity and expressed in milligrams per kilogram of fat free mass (M'), the difference between Nt and BHt remained significant (P = .006). There was a significant correlation of M' with systolic blood pressure (r = .393, P < .0001), HDL-C (r = .382, P < .0001), triglyceride level (r = 308, P < .001), apolipoprotein A-I (r = .190, P = .033), and apolipoprotein B stepwise multiple linear regression analysis, HDL-C emerged as the most significant lipid component in the model for insulin resistance. These data suggest that in American blacks with mild hypertension, the risk for cardiovascular disease may be augmented in the presence of insulin resistance.
Abstract The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline hypertension. Ninety-four American blacks participated (46 men, 48 women, age range 28 to 33 years). Within this group of 94 subjects, there were 60 normotensive (Nt) subjects and 36 subjects with borderline hypertension (BHt), defined as blood pressure >135/85 mm Hg. None of the subjects were diabetic or receiving antihypertension medication. All participants had blood pressure and anthropometric measurements, a fasting lipid profile, an oral glucose tolerance test, and a euglycemic hyperinsulinemic clamp. Insulin-stimulated glucose utilization (M), determined by insulin clamp, was significantly lower in the BHt subjects compared with the Nt subjects (men, Nt 6.91±0.62 versus BHt 5.54±0.65; women, Nt 5.97±0.47 versus BHt 3.79±0.38 mg · kg −1 · min −1 , P =.006). When M was corrected for adiposity and expressed in milligrams per kilogram of fat free mass (M′), the difference between Nt and BHt remained significant ( P =.006). There was a significant correlation of M′ with systolic blood pressure ( r =−.393, P <.0001), HDL-C ( r =.382, P <.0001), triglyceride level ( r =−.308, P <.001), apolipoprotein A-I ( r =.190, P =.033), and apolipoprotein B ( r =−.277, P =.004). When all lipid variables were entered in a stepwise multiple linear regression analysis, HDL-C emerged as the most significant lipid component in the model for insulin resistance. These data suggest that in American blacks with mild hypertension, the risk for cardiovascular disease may be augmented in the presence of insulin resistance.
Author Kushner, Harvey
Marsh, Julian B.
Falkner, Bonita
Tulenko, Thomas
Sumner, Anne E.
AuthorAffiliation Received May 16, 1995; accepted September 13, 1995. From the Medical College of Pennsylvania, Philadelphia, and Hahnemann University, Philadelphia, Pa. Reprint requests to Bonita Falkner, MD, Department of Pediatrics, Medical College of Pennsylvania, 3300 Henry Ave, Philadelphia, PA 19129. E-mail falknerb@medcolpa.edu
AuthorAffiliation_xml – name: Received May 16, 1995; accepted September 13, 1995. From the Medical College of Pennsylvania, Philadelphia, and Hahnemann University, Philadelphia, Pa. Reprint requests to Bonita Falkner, MD, Department of Pediatrics, Medical College of Pennsylvania, 3300 Henry Ave, Philadelphia, PA 19129. E-mail falknerb@medcolpa.edu
Author_xml – sequence: 1
  givenname: Bonita
  surname: Falkner
  fullname: Falkner, Bonita
  organization: Received May 16, 1995; accepted September 13, 1995. From the Medical College of Pennsylvania, Philadelphia, and Hahnemann University, Philadelphia, Pa. Reprint requests to Bonita Falkner, MD, Department of Pediatrics, Medical College of Pennsylvania, 3300 Henry Ave, Philadelphia, PA 19129. E-mail falknerb@medcolpa.edu
– sequence: 2
  givenname: Harvey
  surname: Kushner
  fullname: Kushner, Harvey
– sequence: 3
  givenname: Thomas
  surname: Tulenko
  fullname: Tulenko, Thomas
– sequence: 4
  givenname: Anne E.
  surname: Sumner
  fullname: Sumner, Anne E.
– sequence: 5
  givenname: Julian B.
  surname: Marsh
  fullname: Marsh, Julian B.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2905481$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7583558$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9rVDEUxYNUalv9AC6Eh4irvjH_bpK3HIvawoCCVXAVMkmeTZtJxuQ9S7-9GWZ00YWLS-7h_s4l3HOKjlJOHqGXBC8IEeQdJovl9fcFgSYXRA7qCTohQHnPBRNHrcdy6EFw-gyd1nqLMeaU4mN0LEExAHWCLq9SnWNI3VefapjC7zA9nHersA2unncmue59zNl1X4qvdS6-a-iPPKef3XLjS7AmNcDYu_ocPR1NrP7F4T1D3z5-uL647FefP11dLFe95RJoz0BYpYTjfjSSgR8MOMaxGKV0jFLGFCgr_Jo5KdbKOo45jEIKLDwXI1h2ht7u925L_jX7OulNqNbHaJLPc9VSCqko8Aa-fgTe5rmk9jdN2xmUxAoa9OoAzeuNd3pbwsaUB324T5u_OcxNtSaOxSQb6j-MDhi4Ig2Te8yWXGvxo7ZhMlPIaSomRE2w3uWlMdEtL02gSb3LqznJI-ff3f_z8L3nPsfJl3oX53tf9I03cbrRu5CZwNCTYQBCmuxbYcr-AMW-pJg
CODEN ATVBFA
CitedBy_id crossref_primary_10_1016_S0002_9629_15_40792_X
crossref_primary_10_1097_00000441_200205000_00001
crossref_primary_10_1111_j_1559_4564_2007_06561_x
crossref_primary_10_1016_S1047_2797_97_00208_1
crossref_primary_10_1016_S0026_0495_97_90055_X
crossref_primary_10_1111_j_1559_4564_2006_05695_x
crossref_primary_10_1016_j_metabol_2009_01_010
crossref_primary_10_1016_j_metabol_2004_04_004
crossref_primary_10_1046_j_1523_1755_63_s83_7_x
crossref_primary_10_1016_S1058_9813_99_00008_9
crossref_primary_10_1007_BF02827237
crossref_primary_10_1152_ajpendo_00434_2011
crossref_primary_10_1016_S1047_2797_98_00002_7
crossref_primary_10_1016_j_metabol_2007_02_008
crossref_primary_10_1038_ki_2010_109
crossref_primary_10_1111_liv_15322
crossref_primary_10_1016_j_jash_2010_07_004
crossref_primary_10_1007_s11892_004_0027_3
crossref_primary_10_1046_j_1523_1755_1998_00147_x
crossref_primary_10_1016_S0026_0495_98_90195_0
crossref_primary_10_1161_01_HYP_34_5_1086
crossref_primary_10_1016_S0026_0495_99_90018_5
crossref_primary_10_1212_01_WNL_0000063318_66140_A3
crossref_primary_10_1111_j_1524_6175_2004_03536_x
crossref_primary_10_1097_00000441_200007000_00003
Cites_doi 10.1161/01.hyp.24.5.605
10.1093/ajh/2.6.419
10.2337/diab.37.12.1595
10.1016/S0895-7061(03)00163-8
10.1093/clinchem/18.6.499
10.1210/jcem-62-6-1302
10.1136/bmj.293.6551.840
10.1161/01.ATV.10.3.430
10.1056/NEJM199103143241105
10.1056/NEJM198708063170605
10.1016/0002-9343(91)90211-F
10.1161/01.hyp.20.1.38
10.1056/NEJM198811173192001
10.1056/NEJM198903163201105
10.1093/oxfordjournals.aje.a114230
10.1161/01.hyp.22.1.18
10.1016/0021-9150(94)90155-4
10.1016/0002-8703(84)90667-7
10.2337/diabetes.41.6.715
10.1172/JCI107996
10.1093/ajh/7.11.948
10.1161/01.hyp.15.1.36
10.1079/BJN19770088
10.1161/01.HYP.17.2.170
10.1056/NEJM198908313210905
10.1161/01.ATV.9.5.656
10.1161/circ.54.2.181171
10.1152/ajpendo.1979.237.3.E214
10.1093/ajcn/35.5.1192
10.1093/clinchem/30.6.839
ContentType Journal Article
Copyright 1995 American Heart Association, Inc.
1996 INIST-CNRS
Copyright American Heart Association, Inc. Nov 1995
Copyright_xml – notice: 1995 American Heart Association, Inc.
– notice: 1996 INIST-CNRS
– notice: Copyright American Heart Association, Inc. Nov 1995
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1161/01.ATV.15.11.1798
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4636
EndPage 1804
ExternalDocumentID 26501735
7583558
2905481
10_1161_01_ATV_15_11_1798
00043605-199511000-00002
Genre Clinical Trial
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: DK-46107
– fundername: NHLBI NIH HHS
  grantid: HL-51547
GroupedDBID ---
.3C
.55
.GJ
.Z2
01R
0R~
1J1
23N
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AGINI
AHJKT
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB2
OCUKA
ODA
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
PZZ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
IQODW
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OK1
OLW
RHF
K9.
7X8
ID FETCH-LOGICAL-c4752-356c886d4efa735e9a5d3406f77d32233858c6eb3d76b8cd4045f67606e46f5c3
ISSN 1079-5642
IngestDate Thu Jul 10 19:21:29 EDT 2025
Wed Aug 13 06:53:50 EDT 2025
Wed Feb 19 02:34:20 EST 2025
Mon Jul 21 09:15:48 EDT 2025
Thu Apr 24 23:08:15 EDT 2025
Tue Jul 01 02:21:40 EDT 2025
Fri May 16 03:46:45 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Human
Sensitivity
Race
Negroid
Cardiovascular disease
Exploration
Lipids
Arterial pressure
Borderline hypertension
Insulin
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4752-356c886d4efa735e9a5d3406f77d32233858c6eb3d76b8cd4045f67606e46f5c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.15.11.1798
PMID 7583558
PQID 204287085
PQPubID 49288
PageCount 7
ParticipantIDs proquest_miscellaneous_77678254
proquest_journals_204287085
pubmed_primary_7583558
pascalfrancis_primary_2905481
crossref_citationtrail_10_1161_01_ATV_15_11_1798
crossref_primary_10_1161_01_ATV_15_11_1798
wolterskluwer_health_00043605-199511000-00002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1995-November
PublicationDateYYYYMMDD 1995-11-01
PublicationDate_xml – month: 11
  year: 1995
  text: 1995-November
PublicationDecade 1990
PublicationPlace Philadelphia, PA
Hagerstown, MD
PublicationPlace_xml – name: Philadelphia, PA
– name: Hagerstown, MD
– name: United States
– name: Hagerstown
PublicationTitle Arteriosclerosis, thrombosis, and vascular biology
PublicationTitleAlternate Arterioscler Thromb Vasc Biol
PublicationYear 1995
Publisher American Heart Association, Inc
Lippincott
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott
References e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
(e_1_3_2_26_2) 1991; 15
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
(e_1_3_2_24_2) 1981; 240
e_1_3_2_1_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
(e_1_3_2_31_2) 1989; 32
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
(e_1_3_2_36_2) 1991; 2
(e_1_3_2_25_2) 1990; 1
(e_1_3_2_7_2) 1986; 250
References_xml – ident: e_1_3_2_37_2
  doi: 10.1161/01.hyp.24.5.605
– ident: e_1_3_2_27_2
  doi: 10.1093/ajh/2.6.419
– ident: e_1_3_2_5_2
  doi: 10.2337/diab.37.12.1595
– ident: e_1_3_2_12_2
  doi: 10.1016/S0895-7061(03)00163-8
– ident: e_1_3_2_1_2
– volume: 250
  start-page: E381
  year: 1986
  ident: e_1_3_2_7_2
  publication-title: Am J Physiol
– ident: e_1_3_2_22_2
  doi: 10.1093/clinchem/18.6.499
– ident: e_1_3_2_6_2
  doi: 10.1210/jcem-62-6-1302
– volume: 15
  start-page: 471
  year: 1991
  ident: e_1_3_2_26_2
  publication-title: Int J Obes
– ident: e_1_3_2_29_2
  doi: 10.1136/bmj.293.6551.840
– ident: e_1_3_2_32_2
  doi: 10.1161/01.ATV.10.3.430
– ident: e_1_3_2_11_2
  doi: 10.1056/NEJM199103143241105
– ident: e_1_3_2_8_2
  doi: 10.1056/NEJM198708063170605
– ident: e_1_3_2_10_2
  doi: 10.1016/0002-9343(91)90211-F
– ident: e_1_3_2_14_2
  doi: 10.1161/01.hyp.20.1.38
– ident: e_1_3_2_30_2
  doi: 10.1056/NEJM198811173192001
– ident: e_1_3_2_9_2
  doi: 10.1056/NEJM198903163201105
– volume: 2
  start-page: 489
  year: 1991
  ident: e_1_3_2_36_2
  publication-title: J Am Soc Nephrol
– volume: 240
  start-page: E630
  year: 1981
  ident: e_1_3_2_24_2
  publication-title: Am J Physiol
– ident: e_1_3_2_4_2
  doi: 10.1093/oxfordjournals.aje.a114230
– ident: e_1_3_2_13_2
  doi: 10.1161/01.hyp.22.1.18
– ident: e_1_3_2_38_2
  doi: 10.1016/0021-9150(94)90155-4
– ident: e_1_3_2_3_2
  doi: 10.1016/0002-8703(84)90667-7
– ident: e_1_3_2_15_2
  doi: 10.2337/diabetes.41.6.715
– ident: e_1_3_2_34_2
  doi: 10.1172/JCI107996
– ident: e_1_3_2_17_2
– ident: e_1_3_2_28_2
  doi: 10.1093/ajh/7.11.948
– ident: e_1_3_2_41_2
– ident: e_1_3_2_18_2
  doi: 10.1161/01.hyp.15.1.36
– ident: e_1_3_2_19_2
  doi: 10.1079/BJN19770088
– volume: 32
  start-page: 337
  year: 1989
  ident: e_1_3_2_31_2
  publication-title: N Engl J Med
– ident: e_1_3_2_33_2
  doi: 10.1161/01.HYP.17.2.170
– ident: e_1_3_2_35_2
  doi: 10.1056/NEJM198908313210905
– ident: e_1_3_2_39_2
  doi: 10.1161/01.ATV.9.5.656
– ident: e_1_3_2_40_2
  doi: 10.1161/circ.54.2.181171
– ident: e_1_3_2_23_2
  doi: 10.1152/ajpendo.1979.237.3.E214
– ident: e_1_3_2_20_2
  doi: 10.1093/ajcn/35.5.1192
– ident: e_1_3_2_21_2
  doi: 10.1093/clinchem/30.6.839
– volume: 1
  start-page: 507
  year: 1990
  ident: e_1_3_2_25_2
  publication-title: J Am Soc Nephrol
– ident: e_1_3_2_16_2
– ident: e_1_3_2_2_2
SSID ssj0004220
Score 1.6309097
Snippet The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with borderline...
Abstract The purpose of this study was to determine whether insulin resistance was linked with alterations in plasma lipids in adult young blacks with...
SourceID proquest
pubmed
pascalfrancis
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1798
SubjectTerms Adult
African Continental Ancestry Group
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure
Cardiology. Vascular system
Cardiovascular Diseases - ethnology
Cardiovascular Diseases - etiology
Cardiovascular Diseases - physiopathology
Clinical manifestations. Epidemiology. Investigative techniques. Etiology
Female
Humans
Hypertension - complications
Hypertension - physiopathology
Insulin Resistance
Lipids - blood
Male
Medical sciences
Regression Analysis
Risk Factors
Title Insulin Sensitivity, Lipids, and Blood Pressure in Young American Blacks
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-199511000-00002
https://www.ncbi.nlm.nih.gov/pubmed/7583558
https://www.proquest.com/docview/204287085
https://www.proquest.com/docview/77678254
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA96ohyI-HVYz9M--KTXtV9J28dFlNXjBHFP7i30I4FlP7rYLXL31zuTpGmrq6gvZZumyZLfZJLpzPxCyEvYFJRxyZhXRTL2YhEWXsZK4SUClqMshTVD8cyef2Kzi_jjJb3sAzJVdsmumJTXe_NK_gdVKANcMUv2H5C1jUIB_AZ84QoIw_WvMP5gAskbjELXx0DgkK0W20XVdHGZKjT9tYp3RWcBVL_CGd77agr8htcMd6lTjPNc1A10B4uoZiHA8xTWRXeHDdsgVkPkZEUhXy1NGo3155y1TZdaY31T8xZWvGU9itT-0q5NtanJkahMih41qXm9EvWTzKMsHmtZOpSmYKAzkTJtvzJngUpQmEznXycBhYLJz3UBj-1aoQt2DzLF98uaDTY0T26SWyGYEqgLzz4PGOXDUDNWmP9sPN_Q95tfej4kt01jo13M3S2Md76S-iSUfaYK1PleY_RDs1TJD4MtzPw-uWdsD3eqBekBuSE2D8mdcxNd8YjMjDy5A3k6dbU0nboAuatkye1kyYWqSpbcTpZcLUuPycX7d_O3M8-ctOGVcUIxnYOVacqqWMg8iajIclpFsNWTSVKBxo_Qe1wyUURVwgo87goMAckSMH5FzCQtoyNysKk34glxaUVDKvNAFKAEikKmfiXLPItBWeRh7kuH-N3I8dLQ0ONpKCuuzFEWcD_gMOw8oHDLcdgd8sq-stUcLH-qfDKCw74RZmCdpIFDjjt4uJnKDQ-1wz-lDnlhn4KeRedZvhF123BkvcKvKQ450pjaho1IOMQbYcx1IjNXznaGfL8wVZCgUTE5-OHT3zV0TA77WfWMHOy-teIEdr674rkS3R-gkqeD
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Insulin+sensitivity%2C+lipids%2C+and+blood+pressure+in+young+American+blacks&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Falkner%2C+B&rft.au=Kushner%2C+H&rft.au=Tulenko%2C+T&rft.au=Sumner%2C+A+E&rft.date=1995-11-01&rft.issn=1079-5642&rft.volume=15&rft.issue=11&rft.spage=1798&rft_id=info:doi/10.1161%2F01.ATV.15.11.1798&rft_id=info%3Apmid%2F7583558&rft.externalDocID=7583558
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon